FDA NDC Directory · JSON-LD · Markdown

KADCYLA

NDC 50242-088 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameADO-TRASTUZUMAB EMTANSINE
Labeler / ManufacturerGenentech, Inc.
Marketing categoryBiologic License Application · App BLA125427
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsTRASTUZUMAB EMTANSINE (20 mg/mL)
Marketing started20130222
Package count1

External sources

Source: openFDA. Public-domain (CC0).